B7-H3 has been characterized as a pan-cancer antigen overexpressed in a variety of solid tumors including neuroblastoma and pediatric sarcomas, for which CD276-CAR-T cells are being investigated [222]. This evidence concerns the gene CD276 and neuroblastoma.